Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Internet Vikings are an unstoppable force in the U.S., as they commence operations in Louisiana

Internet Vikings is pleased to announce the launch of its hosting services in Louisiana, which is yet another milestone along the road towards its nation-wide expansion across the U.S. market. Since its first bold step into the new American online gaming and sports betting market in 2021, the global iGaming hosting provider has already successfully obtained the necessary rights to legally operate and also established customer bases in multiple states, including New Jersey and Michigan.  Research reveals quite clearly that Louisiana has long held a concrete policy that

Nina Jönsson appointed as new CEO of ICA Gruppen

Per Strömberg has chosen to leave ICA Gruppen, where he has served as CEO since 2012. He will leave his CEO role on 31 December 2022. The Board of Directors has appointed Nina Jönsson as the new CEO. She is currently CEO of Plantagen, with more than 20 years of experience from various senior positions in the retail and food industries. At the beginning of 2023, Per Strömberg will be proposed as member of ICA Gruppen’s board of directors.“I am very happy that Nina Jönsson has accepted the job as CEO of ICA Gruppen,” comments Claes Göran Sylvén, Chairman of ICA Gruppen. “With the combination

Eric Lundberg new CEO of ICA Sweden, and Monika Magnusson new CEO of Apotek Hjärtat

Anders Svensson has chosen to leave ICA Sweden after 13 years in the role as CEO. Eric Lundberg, currently CEO of Apotek Hjärtat, has been named as the new CEO of ICA Sweden. In connection with this, Monika Magnusson, Director of Sales at Apotek Hjärtat, has been named to succeed Eric Lundberg as the new CEO of Apotek Hjärtat.“Today I am happy to announce the appointment of two new CEOs within ICA Gruppen, who we have recruited internally. Both are respected leaders who are passionate about developing our businesses together with all of our competent employees. At the same time, I want to

BioStock: Strong growth for Invent Medic in Q2

When Anna Lindström took over as CEO of Invent Medic just under a year ago, the focus was crystal clear – sales should be increased. After a number of new strategic initiatives, growth reached just over 60 per cent in the second quarter of 2022. At the same time, cost savings have started to show effect. The company will continue to look firmly ahead, hoping to present further growth news in the near future.Read the full article at biostock.se:https://www.biostock.se/en/2022/08/strong-growth-for-invent-medic-in-q2/This is a press release from BioStock - Connecting Innovation & Capital.

Hope for leukaemia patients through discovery at Karolinska University Hospital

In a recently published study, Nikolas Herold and Martin Jädersten from Karolinska University Hospital show how acute myeloid leukaemia can be treated more effectively. They have reused an already proven medicinal product.Acute myeloid leukaemia (AML) is an aggressive blood cancer with a high mortality that affects about 350 people annually in Sweden. Over 70 percent of patients die within five years of falling ill. One reason for the high mortality rate is that chemotherapy often has an inadequate effect, which causes the disease to reoccur after some time. The protein (SAMHD1) in the

IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study

· Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study. · DIVE is designed to measure the effectiveness of IRRAflow to treat intraventricular hemorrhage versus standard EVD treatment. · The Neurosurgery and Neurology Departments at The Mount Sinai Hospital were recently ranked 9th in the US, according to U.S. News and World Report.Stockholm, August 23, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products

AFRY provides basic engineering for Yash Pakka’s sustainable packaging production expansion

Yash Pakka Limited has awarded AFRY basic engineering assignment for the Ayodhya packaging material production facility expansion project in India. The expansion enables Yash Pakka to increase sustainable packaging materials production and, at the same time, continue to be low-carbon with 100% bio-based energy.Yash Pakka is a leading provider of packaging solutions in paper and compostable tableware. Company’s bagasse fiber-based products are compostable, fossil-free and low-carbon alternatives integrating bio-based solutions that provide a green alternative to single-use plastic, styrofoam

Interim report January – June 2022

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value fell to SEK 158 per share, compared with SEK 216 per share at the start of the year. This is a decrease of 25.5 per cent, adjusted for dividends. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) decreased by 27.9 per cent. The net asset value was SEK 169 per share at 22 August.[1] · The total return on the Latour share was -44.3 per cent during the period measured against the SIXRX, which fell 27.9 per cent. INDUSTRIAL OPERATIONS The second quarter · The industrial operations’ order intake

Immunovia to present at Gilmartin Group’s Emerging Growth Company Showcase

LUND, SWEDEN – Immunovia today announced it will participate in Gilmartin Group's Emerging Growth Company Showcase on August 31, 2022.   Philipp Mathieu, CEO and President, and Jeff Borcherding, US CEO, are scheduled to present on Wednesday, August 31, 2022 at 9:00 am ET (15:00 pm CET).   A live and archived webcast will be available on the “Investors” section of the Immunovia website at https://investor.immunovia.com/.   For more information, please contact:Karin Almqvist LiwendahlCFOkarin.almqvist.liwendahl@immunovia.com+46 70 911 56 08  About Immunovia

Saga Pure ASA: Invitation to presentation of Q2 2022 results on 25 August 2022 at 12:00 (CEST)

In connection with the release of the results for Q2 2022, Saga Pure ASA invites to the following event: Thursday 25 May 2022 at 12.00 CET Live webcast of the company Q2 Report and Q&A. The presentation will be held at Haakon VIIs gate 2, Oslo. The Q2 Report and Presentation will be available at www.sagapure.com and by a stock exchange release from Saga Pure ASA 25 August 2022. All others are welcome follow the Q2 presentation live on webcast. Link to webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20220825_9/ ENDS For additional information, please

Medivir to present at the Erik Penser Bank Company Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Erik Penser Bank Company Day on August 24, 2022. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox).The presentation will be available after the meeting on Medivirs website; www.medivir.com.For additional information, please contactMagnus Christensen, CFO, Medivir ABTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.comMedivir in briefMedivir develops innovative drugs with a focus

Etteplan is planning for a rights offering of approximately 110–125 million euros

Etteplan Oyj, Stock exchange release, Inside information, August 23, 2022 at 09:30 a.m. EEST Etteplan is planning for a rights offering of approximately 110–125 million euros NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Etteplan Oyj (the ”Company”) commences preparations for a rights offering of approximately 110–125 million euros. The subscription period for the offering is expected

The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, OR CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. Lund, Sweden – Today, 23 August 2022, is the first day of the subscription period in Clinical Laserthermia Systems AB’s (publ), (”CLS” or the “Company”) issue of units, with preferential right for existing shareholders (the “Rights Issue”). The public is also invited to subscribe

FluoGuide has submitted a Clinical Trial Application (CTA) to the Danish Medicines Agency to initiate phase II trial with FG001 in head and neck cancer

Copenhagen, Denmark 23 August2022– FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted a CTA to initiate a phase II trial in head and neck cancer. The clinical trial will be conducted at Rigshospitalet in Denmark.Following approval from the Danish Medicines Agency, FluoGuide will initiate the phase II trial in collaboration with Department of Otolaryngology, Head & Neck Surgery and Audiology at the University Hospital, Rigshospitalet, in Denmark. Principal investigator is Anders Christensen, MD, Ph.D. The phase IIa trial is designed to

DecideAct signs with Hope Aero – Canada’s leading aircraft component maintenance specialist

The Danish software company DecideAct, which offers a SaaS solution that helps companies with Strategy Execution Management, has signed a contract with the Canadian company Hope Aero, Canada's leading specialist in the maintenance of aircraft components. The agreement includes both an expert service to help clarify the strategic priorities and DecideAct's infrastructure to implement the strategy.Hope Aero is a key player in maintaining aircraft safety focusing on propeller, wheel and brake repair and overhaul, dynamic balancing, and NDT (Non-destructive testing). Within this field, Hope

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital23 August 2022 at 9.15 EET Nordea has today cancelled 17,520,108 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,735,542,696. The total number of votes attached to the shares is 3,735,542,696. The cancellation of the shares was registered with the Finnish Trade Register on 23 August 2022. The company holds 2,927,860

Interim report April – June 2022

Second quarter in brief · Net sales amounted to 18.7 million SEK (11.8), which means a sales growth of 59 percent. · Operating profit amounted to 4.4 million SEK (0.1). · Net profit for the period amounted to 5.1 million SEK (-0.2). · Earnings per share amounted to 0.13 SEK (-0.01). First half year in brief ·Net sales for the first half year amounted to 28.6 million SEK (26.5), which means a sales growth of 8 percent. ·Operating profit amounted to 0.8 million SEK (2.6). · Profit for the period amounted to 1.7 million SEK (2.5). · Earnings per

Statement from the Board of Directors of Semcon in response to Etteplan’s public takeover bid

Background This statement is made by the Board of Directors of Semcon AB (publ) (“Semcon” or the “Company") pursuant to section II.19 of Nasdaq Stockholm’s Takeover Rules (the “Takeover Rules”). Etteplan Oyj (“Etteplan”) has today, on 23 August 2022, submitted a public cash takeover bid to the shareholders of Semcon to transfer all of their respective shares in Semcon to Etteplan (the “Offer”). According to the terms of the Offer, Etteplan offers a cash consideration of SEK 149 per share in Semcon (the “Offer Price”) corresponding to a total value of approximately SEK 2.7 billion[[1]].

OssDsign AB (publ) publishes Q2 2022 Interim Report

OssDsign AB (publ) announces that the interim report for Q2 2022 is now available as a pdf on the company's website www.ossdsign.com. A pdf version is also attached to this press release.For further information, please contact:Morten Henneveld, CEO, OssDsign ABTel: +46 73 382 43 90, email: morten.henneveld@ossdsign.com Certified Adviser:Erik Penser Bank AB is the company’s Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email: certifiedadviser@penser.se. About OssDsign:OssDsign is a developer and

My Life launches on Snapchat

New instant game produced by Nitro Games launches on the Snapchat platform Nitro Games has today announced that a new mobile game produced for Snapchat has been released. The game is called My Life and it’s available now for Snapchatters around the world. My Life is a casual sim-style game where players get to choose a career in anything from arts to medicine, earn money from their profession, and furnish their virtual apartments with trendy or quirky items. Players can visit each others’ virtual homes, and connect to create a neighborhood. My Life is an instant game, meaning

Modus Therapeutics publishes interim report for the second quarter 2022

STOCKHOLM, SWEDEN - 23 August 2022: Modus Therapeutics Holding AB (” Modus Therapeutics”) hereby publishes an interim report for the second quarter 2022. The report is available as an attached document and on the company's website (www.modustx.com/investors/financial-reports.html). Below is a summary of the interim reportThe second quarter in figures · The loss after tax amounted to TSEK 2 992 (2 533). · The loss per share amounted to SEK 0,19 (0,26). · The cash flow from current operations was negative in the amount of TSEK 3 228 (2 299). The first half-year in figures ·

Q2 Report – 30 June 2022

Flexion Mobile reports new growth record and hits USD 20 million revenue milestone for the quarter. Gross profit soars by 211% resulting in adjusted EBITDA[‡] of GBP 1.4 million.April-June 2022 performance · Total revenue increased by 127% to GBP 17.7m (7.8)* · Gross profit increased by 211% to GBP 2.9m (0.9) · Adjusted EBITDA[‡] increased to GBP 1.4m (0.02) · Operating result decreased to GBP -0.4m (-0.05) · Earnings per share amounted to GBP -1.42 pence  (-0.13 pence) · Cash and cash equivalents amounted to GBP 8.4m (15.6) January-June 2022 performance · Total

Alleima hosts its first Capital Markets Day

Alleima, formerly Sandvik Materials Technology, which is expected to be listed on Nasdaq Stockholm, today hosts its first Capital Markets Day, in Sandviken, Sweden. At the event, the executive management will present trends and characteristics of the Alleima markets, business, financial performance, and strategic direction. Alleima advances industries through materials technology. Alleima offers niched and premium products to a wide set of industries and has claimed strong market positions through its leading metallurgy expertise, global reach, and fully integrated value chain. The

Alleima hosts its first Capital Markets Day

Alleima, formerly Sandvik Materials Technology, which is expected to be listed on Nasdaq Stockholm, today hosts its first Capital Markets Day, in Sandviken, Sweden. At the event, the executive management will present trends and characteristics of the Alleima markets, business, financial performance, and strategic direction.Alleima advances industries through materials technology. Alleima offers niched and premium products to a wide set of industries and has claimed strong market positions through its leading metallurgy expertise, global reach, and fully integrated value chain. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top